181 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
7 May 24
Ligand Reports First Quarter 2024 Financial Results
4:03pm
for the additional investment.
On April 3, Ligand announced the creation of Pelthos Therapeutics under the leadership of Scott Plesha as Chief Executive
8-K
qq1bbvor
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
425
EX-99.1
80zqrqae
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
2601 rwajfm4ruim
21 Jun 22
Regulation FD Disclosure
6:19am
425
EX-99.2
8frh7 vq7
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.1
fbmsajzxdxc jvdzo2w
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.3
e02n8rda
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.3
vbuwylml8kao o5tr5
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
uae04j2l91fjk
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.2
0aqvkeu
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm